Safarinejad 2008 — Bremelanotide Salvage ED

Urology·March 1, 2008

Mohammad Reza Safarinejad, Seyyed Yousof Hosseini

Summary

Positive clinical results in 33.5% of bremelanotide group vs 8.5% placebo (p=0.03). Bremelanotide can be an alternative treatment for ED in men who do not respond to sildenafil.

Study Details

Study Design

Randomized, double-blind, placebo-controlled study

Indication

Erectile dysfunction in sildenafil non-responders

Intervention

Intranasal bremelanotide 10 mg vs placebo

Species

Human

Sample Size

342 subjects

Risk of Bias Assessment

Non-randomized; single author